| Henry M Jones, MD | |
|
2015 Jackson Street, Radiology Dept, Anderson, IN 46016-4339 | |
| (765) 649-2511 | |
| Not Available |
| Full Name | Henry M Jones |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 36 Years |
| Location | 2015 Jackson Street, Anderson, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487675120 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 5069601 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mountain View Regional Medical Center | Las cruces, NM | Hospital |
| Havasu Regional Medical Center | Lake havasu city, AZ | Hospital |
| Memorial Medical Center | Las cruces, NM | Hospital |
| Fountain Valley Regional Hospital & Medical Center | Fountain valley, CA | Hospital |
| Desert Regional Medical Center | Palm springs, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eagle Partners Pllc | 9032205752 | 92 |
| Golden State Imaging Associates Inc | 1254761315 | 230 |
| Imaging Associates Of New Mexico Llc | 4981970233 | 97 |
| Mountain Radiology Inc | 4688666761 | 71 |
| Singleton Associates Pa | 6305731118 | 691 |
| Sonoran Radiology Ltd | 3375964505 | 367 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Quantum Medical Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164475869 PECOS PAC ID: 3577468040 Enrollment ID: O20070910000644 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Ellis Bandt Birkin Kollins & Wong Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578584678 PECOS PAC ID: 4486568946 Enrollment ID: O20111020000050 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Southwest Diagnostic Imaging Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902896236 PECOS PAC ID: 7416946199 Enrollment ID: O20130227000152 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Eagle Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548450976 PECOS PAC ID: 9032205752 Enrollment ID: O20140317001788 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Singleton Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538107875 PECOS PAC ID: 6305731118 Enrollment ID: O20150701002707 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Imaging Associates Of New Mexico Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629592464 PECOS PAC ID: 4981970233 Enrollment ID: O20180220001048 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Specialists In Medical Imaging Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841687951 PECOS PAC ID: 2163733544 Enrollment ID: O20180522002986 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Sierra Vista Hospital 69 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760446009 PECOS PAC ID: 0143122416 Enrollment ID: O20191023002871 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Golden State Imaging Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144872052 PECOS PAC ID: 1254761315 Enrollment ID: O20200414001788 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Sonoran Radiology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033745708 PECOS PAC ID: 3375964505 Enrollment ID: O20200701001467 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Empire State Radiology P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255962783 PECOS PAC ID: 4385075241 Enrollment ID: O20200826000703 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Mountain Radiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093823742 PECOS PAC ID: 4688666761 Enrollment ID: O20210520001495 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Entity Name | Consultants In Radiology, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922034602 PECOS PAC ID: 9931157609 Enrollment ID: O20221130001156 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Henry M Jones, MD 2015 Jackson Street, Radiology Dept, Anderson, IN 46016-4339 Ph: (765) 649-2511 | Henry M Jones, MD 2015 Jackson Street, Radiology Dept, Anderson, IN 46016-4339 Ph: (765) 649-2511 |
News Archive
State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system - at least at the appellate level," according to a Wall Street Journal editorial.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.
Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
The Biotechnology Industry Organization (BIO) today applauded the announcement of over $600 million in grants and loan guarantees to help build 19 new biorefinery projects to produce advanced biofuels and biobased chemicals from renewable feedstocks. The funding represents the largest single federal investment in advanced biorefineries to date.
› Verified 6 days ago
Joseph P Porcaro, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1515 N Madison Avenue, Anderson, IN 46011 Phone: 765-298-5181 Fax: 765-298-5821 | |
James Edwin Currier, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1340 N Madison Ave, Anderson, IN 46011 Phone: 765-622-7600 Fax: 765-622-7676 |